RobertA.ChapmanMD

Oncology • Detroit, MI

Director, Josephine Ford Cancer Center Division Head, Hematology/Oncology

Join to view full profile

Are you Dr. Chapman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 68 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
Henry Ford Health System
2799 West Grand Boulevard
Detroit, MI 48202
Phone+1 313-916-2600
Is this information wrong?

Summary

Dr. Robert Chapman, MD is an oncologist in Detroit, Michigan. He is currently licensed to practice medicine in Michigan. He is affiliated with Henry Ford Hospital and is a Director at Hematology/Oncology.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1979 - 1981
Henry Ford HospitalResidency, Internal Medicine, 1976 - 1979
Weill Cornell MedicineClass of 1976

Certifications & Licensure

MI State Medical License 1981 - 2021

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
Completed
Phase 3
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
Active, not recruiting
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01
Completed
Phase 3
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Start of enrollment: 2006 Oct 01
Completed
Phase 3
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
Active, not recruiting
Phase 3
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery Start of enrollment: 2008 Oct 01
Completed
Phase 1
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer Start of enrollment: 2009 Feb 01
Completed
Phase 2
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Start of enrollment: 2009 Sep 01
Recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Start of enrollment: 2009 Nov 17
Active, not recruiting
Phase 3
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma Start of enrollment: 2010 Mar 15
Active, not recruiting
Phase 1, Phase 2
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
Completed
Not Applicable
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Start of enrollment: 2010 Dec 01
Completed
Phase 2
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 2011 Jan 07
Completed
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy Start of enrollment: 2011 Aug 09
Active, not recruiting
Phase 2
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 2
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
Stress Management for Cancer Patients: How Well Does it Work? (C2H-D) Start of enrollment: 2013 Nov 01
Completed
Not Applicable
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

16 citations
Role of Kindness in Cancer Care.
Leonard L. Berry, Tracey S. Danaher, Robert Chapman, Rana Awdish> ;Journal of Oncology Practice. 2017 Oct 16
48 citations
Discussing prognosis and treatment goals with patients with advanced cancer: A qualitative analysis of oncologists' language.
Wen ying Sylvia Chou, Lauren M. Hamel, Chan L. Thai, David Debono, Robert Chapman, Terrance L. Albrecht, Louis A. Penner, Susan Eggly> ;Health Expectations. 2017 Oct 1
12 citations
Clues to the Blues: Predictors of Self-Reported Mental and Emotional Health Among Older African American Men.
Jamie A. Mitchell, Daphne C. Watkins, Deirdre A. Shires, Robert Chapman, Janice Burnett> ;American Journal of Men's Health. 2017 Sep 1
50 citations
Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists
Susan Eggly, Lauren M. Hamel, Tanina Foster, Terrance L. Albrecht, Robert Chapman, Felicity W. K. Harper, Hayley S. Thompson, Jennifer J. Griggs, Richard Gonzalez, Lis...> ;Patient Education and Counseling. 2017 May 1
31 citations
Do Patients and Oncologists Discuss the Cost of Cancer Treatment? An Observational Study of Clinical Interactions Between African American Patients and Their Oncologists
Lauren M. Hamel, Louis A. Penner, Susan Eggly, Robert Chapman, Justin Frank Antoni Klamerus, Michael S. Simon, Sarah C. E. Stanton, Terrance L. Albrecht> ;Journal of Oncology Practice. 2017 Mar 1
2 citations
Predicting Incongruence between Self-reported and Documented Colorectal Cancer Screening in a Sample of African American Medicare Recipients
Mark Manning, Janice Burnett, Robert Chapman> ;Behavioral Medicine. 2016 Oct 1
178 citations
The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions
Louis A. Penner, John F. Dovidio, Richard Gonzalez, Terrance L. Albrecht, Robert Chapman, Tanina Foster, Felicity W.K. Harper, Nao Hagiwara, Lauren M. Hamel, Anthony F...> ;Journal of Clinical Oncology. 2016 Sep 27
30 citations
Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image Analysis
Ann G. Schwartz, Christine M. Lusk, Angela S. Wenzlaff, Donovan Watza, Stephanie S. Pandolfi, Laura Mantha, Michele L. Cote, Ayman O. Soubani, Garrett Walworth, Antoin...> ;Cancer Epidemiology, Biomarkers & Prevention. 2016 Sep 1
2 citations
340B Drug Pricing Program Reform-Reply.
Hagop M. Kantarjian, Robert Chapman> ;JAMA Oncology. 2016 Mar 1
30 citations
An Analysis of Race-related Attitudes and Beliefs in Black Cancer Patients: Implications for Health Care Disparities.
Louis A. Penner, John F. Dovidio, Nao Hagiwara, Tanina Foster, Terrance L. Albrecht, Robert Chapman, Susan Eggly> ;Journal of Health Care for the Poor and Underserved. 2016 Jan 1
8 citations
Value of the 340B Drug Discount Program.
Hagop M. Kantarjian, Robert Chapman> ;JAMA Oncology. 2015 Nov 1
25 citations
Critical Shortage of African American Medical Oncologists in the United States.
Lauren M. Hamel, Robert Chapman, Mary Malloy, Susan Eggly, Louis A. Penner, Anthony F. Shields, Michael S. Simon, Justin Frank Antoni Klamerus, Charles A. Schiffer, Te...> ;Journal of Clinical Oncology. 2015 Sep 21
7 citations
Fatalistic Beliefs About Cancer Prevention Among Older African American Men.
Jamie A. Mitchell, Mark Manning, Deirdre A. Shires, Robert Chapman, Janice Burnett> ;Research on Aging. 2015 Aug 1
12 citations
Measuring the Use of Examination Room Time in Oncology Clinics: A Novel Approach to Assessing Clinic Efficiency and Patient Flow
Lauren M. Hamel, Robert Chapman, Susan Eggly, Louis A. Penner, Rifky Tkatch, Jennifer Vichich, Terrance L. Albrecht> ;Journal of Oncology Practice. 2014 Sep 23
41 citations
Unexpected findings in the exploration of African American underrepresentation in biospecimen collection and biobanks
Nao Hagiwara, Lisa Berry-Bobovski, Carie Francis, Lauren Ramsey, Robert Chapman, Terrance L. Albrecht> ;Journal of Cancer Education. 2014 Sep 1
9 citations
Modeling the sustainability of community health networks: novel approaches for analyzing collaborative organization partnerships across time.
Mark Manning, Aliccia Bollig-Fischer, Lisa Berry Bobovski, Peter A. Lichtenberg, Robert Chapman, Terrance L. Albrecht> ;Translational Behavioral Medicine. 2014 Mar 1
146 citations
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
Panayiotis Savvides, Govardhanan Nagaiah, Pierre Lavertu, Pingfu Fu, John J. Wright, Robert Chapman, Jay Wasman, Afshin Dowlati, Scot C. Remick> ;Thyroid. 2013 Apr 29
36 citations
Development of a question prompt list as a communication intervention to reduce racial disparities in cancer treatment.
Susan Eggly, Rifky Tkatch, Louis A. Penner, Lorna M. Mabunda, Janella Hudson, Robert Chapman, Jennifer J. Griggs, Richard A. Brown, Terrance L. Albrecht> ;Journal of Cancer Education. 2013 Feb 26
1 citations
Salmonella-related mycotic aortic aneurysm heralding a diagnosis of multiple myeloma.
Javier Munoz, Michael Stoltenberg, Robert Chapman> ;American Journal of Hematology. 2012 Aug 1
56 citations
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336).
Robert P. Whitehead, Cathryn Rankin, Paulo M. Hoff, Philip J. Gold, Kevin G. Billingsley, Robert Chapman, Lucas Wong, John H. Ward, James L. Abbruzzese, Charles D. Blanke> ;Investigational New Drugs. 2009 Oct 1
105 citations
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
A. Oliver Sartor, Catherine M. Tangen, Maha Hussain, Mario A. Eisenberger, Minoti Parab, Joseph A. Fontana, Robert Chapman, Glenn Mills, Derek Raghavan, E. David Crawford> ;Cancer. 2008 Jun 1
5 citations
A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-smal...
Samir H. Patel, Munther Ajlouni, Robert Chapman, Mei Lu, Benjamin Movsas, Jae Ho Kim> ;Journal of Thoracic Oncology. 2007 Sep 1
43 citations
Chemotherapy in Patients ≥80 with Advanced Non-small Cell Lung Cancer: Combined Results from SWOG 0027 and LUN 6
Paul J. Hesketh, Rogerio Lilenbaum, Kari Chansky, Afshin Dowlati, Patricia Graham, Robert Chapman, John Crowley, David R. Gandara> ;Journal of Thoracic Oncology. 2007 Jun 1
26 citations
Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy
Afshin Dowlati, S. Subbiah, Matthew M. Cooney, Kimberly Rutherford, Tarek Mekhail, Pingfu Fu, Robert Chapman, A. Ness, Tania Cortas, Joel N. Saltzman, Nathan Levitan, ...> ;Lung Cancer. 2007 Jun 1
20 citations
Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the So...
Paul J. Hesketh, Kari Chansky, Derick H Lau, James H. Doroshow, Carol M. Moinpour, Robert Chapman, J. Wendall Goodwin, Howard M. Gross, John Crowley, David R. Gandara> ;Journal of Thoracic Oncology. 2006 Jul 1
Join now to see all

Press Mentions

Medical News in Polk (Jan. 7, 2020)January 7th, 2020
Court Rejects Trump’s Cuts in Payments for Prescription DrugsJanuary 7th, 2019

Hospital Affiliations

Henry Ford HospitalDetroit, Michigan